Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Total Assets 2010-2024 | TAK

Takeda Pharmaceutical total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Takeda Pharmaceutical total assets for the quarter ending September 30, 2024 were $103.857B, a 3.82% decline year-over-year.
  • Takeda Pharmaceutical total assets for 2024 were $104.251B, a 0.93% increase from 2023.
  • Takeda Pharmaceutical total assets for 2023 were $103.287B, a 11.93% decline from 2022.
  • Takeda Pharmaceutical total assets for 2022 were $117.284B, a 3.37% decline from 2021.
  
Takeda Pharmaceutical Annual Total Assets
(Millions of US $)
2024 $104,251
2023 $103,287
2022 $117,284
2021 $121,376
2020 $117,954
2019 $124,851
2018 $36,958
2017 $40,509
2016 $31,740
2015 $39,095
2014 $45,691
2013 $47,863
2012 $45,428
2011 $33,571
2010 $30,358
2009 $13,338
Takeda Pharmaceutical Quarterly Total Assets
(Millions of US $)
2024-06-30 $103,857
2024-03-31 $104,251
2023-12-31 $96,716
2023-09-30 $102,616
2023-06-30 $107,987
2023-03-31 $103,287
2022-12-31 $95,883
2022-09-30 $105,040
2022-06-30 $108,304
2022-03-31 $117,284
2021-12-31 $111,747
2021-09-30 $114,299
2021-06-30 $115,181
2021-03-31 $121,376
2020-12-31 $117,947
2020-09-30 $116,699
2020-06-30 $117,309
2020-03-31 $117,954
2019-12-31 $119,890
2019-09-30 $119,785
2019-06-30 $123,309
2018-12-31 $51,328
2018-06-30 $38,268
2017-06-30 $39,113
2016-06-30 $35,498
2015-06-30 $35,431
2015-03-31 $39,095
2014-12-31 $40,950
2014-09-30 $43,889
2014-06-30 $43,486
2014-03-31 $45,691
2013-12-31 $44,258
2013-09-30 $42,957
2013-06-30 $39,730
2013-03-31 $47,863
2012-12-31 $46,540
2012-09-30 $44,223
2012-06-30 $43,349
2012-03-31 $45,428
2011-12-31 $44,136
2011-09-30 $45,141
2011-03-31 $33,571
2010-03-31 $30,358
2009-09-30 $0
2009-03-31 $28,165
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $41.110B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.844B 28.80
Chugai Pharmaceutical (CHGCY) Japan $70.231B 27.36
Sandoz Group AG (SDZNY) Switzerland $19.633B 0.00
Merck (MKKGY) Germany $18.831B 16.86
Astellas Pharma (ALPMY) Japan $17.264B 15.90
United Therapeutics (UTHR) United States $16.024B 15.76
Neurocrine Biosciences (NBIX) United States $14.505B 38.41
Summit Therapeutics (SMMT) United States $14.034B 0.00
Shionogi (SGIOY) Japan $12.114B 12.14
Orion OYJ (ORINY) Finland $7.195B 20.23
Stevanato Group S.p.A (STVN) Italy $6.920B 44.80
Madrigal Pharmaceuticals (MDGL) United States $6.404B 0.00
Corcept Therapeutics (CORT) United States $5.795B 43.90
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.456B 0.00
Grifols, S.A (GRFS) Spain $4.999B 0.00
Ionis Pharmaceuticals (IONS) United States $4.963B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.464B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.717B 12.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.559B 15.30
Recursion Pharmaceuticals (RXRX) United States $2.551B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.176B 0.00
Soleno Therapeutics (SLNO) United States $2.021B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.999B 0.00
Hypermarcas (HYPMY) Brazil $1.932B 0.00
Indivior (INDV) United States $1.606B 6.54
BioCryst Pharmaceuticals (BCRX) United States $1.543B 0.00
Evotec AG (EVO) Germany $1.456B 0.00
Dyne Therapeutics (DYN) United States $1.438B 0.00
Xencor (XNCR) United States $1.346B 0.00
Guardian Pharmacy Services (GRDN) United States $1.310B 0.00
Ocular Therapeutix (OCUL) United States $1.259B 0.00
ARS Pharmaceuticals (SPRY) United States $1.222B 0.00
Harrow (HROW) United States $1.206B 0.00
Ardelyx (ARDX) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.147B 0.00
Collegium Pharmaceutical (COLL) United States $1.076B 5.87
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Bioventus (BVS) United States $0.815B 25.74
Cronos Group (CRON) Canada $0.761B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.747B 0.00
Relay Therapeutics (RLAY) United States $0.747B 0.00
USANA Health Sciences (USNA) United States $0.648B 12.02
Ironwood Pharmaceuticals (IRWD) United States $0.586B 0.00
Elite Pharmaceuticals (ELTP) United States $0.526B 0.00
Verve Therapeutics (VERV) United States $0.520B 0.00
Savara (SVRA) United States $0.503B 0.00
Altimmune (ALT) United States $0.488B 0.00
ProKidney (PROK) United States $0.484B 0.00
Xeris Biopharma Holdings (XERS) United States $0.477B 0.00
Tourmaline Bio (TRML) United States $0.462B 0.00
OmniAb (OABI) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.452B 0.00
Siga Technologies (SIGA) United States $0.444B 5.19
Esperion Therapeutics (ESPR) United States $0.435B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.422B 0.00
Organogenesis (ORGO) United States $0.420B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.355B 143.79
Korro Bio (KRRO) United States $0.347B 0.00
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.68
Heron Therapeutics (HRTX) United States $0.248B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.247B 0.00
Avita Medical (RCEL) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.212B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Inhibikase Therapeutics (IKT) United States $0.189B 0.00
CytoDyn (CYDY) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Acrivon Therapeutics (ACRV) United States $0.180B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.168B 0.00
Lexeo Therapeutics (LXEO) United States $0.168B 0.00
Nektar Therapeutics (NKTR) United States $0.165B 0.00
Silence Therapeutics (SLN) United Kingdom $0.153B 0.00
Jupiter Neurosciences (JUNS) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
Nanobiotix S.A (NBTX) France $0.143B 0.00
Telomir Pharmaceuticals (TELO) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.135B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.099B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Protara Therapeutics (TARA) United States $0.094B 0.00
Pyxis Oncology (PYXS) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Regulus Therapeutics (RGLS) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.68
Galectin Therapeutics (GALT) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Century Therapeutics (IPSC) United States $0.077B 0.00
Journey Medical (DERM) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.071B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Mural Oncology (MURA) Ireland $0.068B 0.00
AleAnna (ANNA) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
OptiNose (OPTN) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
FibroGen (FGEN) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.041B 0.00
Scienture Holdings (SCNX) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioVie (BIVI) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Traws Pharma (TRAW) United States $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
SciSparc (SPRC) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00